Utal AK, Stopka AL, Roy M, Coleman PD.
PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease.
Neuroscience. 1998 Oct;86(4):1055-63.
PubMed.
We believe that the dramatic reduction of the calmodulin binding protein, PEP-19, in basal ganglia in Huntington's disease, but not in Parkinson's disease or Downs, may relate to the regional neuronal vulnerability of this disease as well as to a potential mechanism for this vulnerability.
Comments
Banner Research Institute
We believe that the dramatic reduction of the calmodulin binding protein, PEP-19, in basal ganglia in Huntington's disease, but not in Parkinson's disease or Downs, may relate to the regional neuronal vulnerability of this disease as well as to a potential mechanism for this vulnerability.
Make a Comment
To make a comment you must login or register.